Skip to main content
SpringerLink
Log in

Authors’ Response to “Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery”

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

The Original Article was published on 15 September 2021

A Systematic Review to this article was published on 08 July 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Trentino KM, Mace H, Hofmann A. Preoperative intravenous iron for iron deficiency is cost-effective prior to major elective surgery. Pharmacoeconomics. 2021. https://doi.org/10.1007/s40273-021-01083-w.

    Article  PubMed  Google Scholar 

  2. Avau B, Van Remoortel H, Laermans J, Bekkering G, Fergusson D, Georgsen J, et al. Lack of cost-effectiveness of preoperative erythropoiesis-stimulating agents and/or iron therapy in anaemic, elective surgery patients: a systematic review and updated analysis. Pharmacoeconomics. 2021. https://doi.org/10.1007/s40273-021-01044-3.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Trentino KM, Mace HS, Symons K, Sanfilippo FM, Leahy MF, Farmer SL, et al. Screening and treating pre-operative anaemia and suboptimal iron stores in elective colorectal surgery: a cost effectiveness analysis. Anaesthesia. 2021;76(3):357–65.

    Article  CAS  Google Scholar 

  4. Pandis N, Cobourne MT. Clinical trial design for orthodontists. J Orthod. 2013;40(2):93–103.

    Article  Google Scholar 

  5. Mueller MM, Van Remoortel H, Meybohm P, Aranko K, Aubron C, Burger R, et al. Patient blood management: recommendations from the 2018 Frankfurt Consensus Conference. JAMA. 2019;321(10):983–97.

    Article  Google Scholar 

  6. Roman MA, Abbasciano RG, Pathak S, Oo S, Yusoff S, Wozniak M, et al. Patient blood management interventions do not lead to important clinical benefits or cost-effectiveness for major surgery: a network meta-analysis. Br J Anaesth. 2021;126(1):149–56.

    Article  Google Scholar 

  7. Van Remoortel H, Laermans J, Avau B, Bekkering G, Georgsen J, Manzini PM, et al. Effectiveness of iron supplementation with or without erythropoiesis-stimulating agents on red blood cell utilization in patients with preoperative anaemia undergoing elective surgery: a systematic review and meta-analysis. Transfus Med Rev. 2021;35(2):103–24.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Evidence-Based Practice (CEBaP), Belgian Red Cross, Motstraat 42, 2800, Mechelen, Germany

    Bert Avau, Hans Van Remoortel & Emmy De Buck

  2. Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven, Leuven, Belgium

    Emmy De Buck & Philippe Vandekerckhove

  3. Belgian Red Cross, Blood Services, Mechelen, Belgium

    Veerle Compernolle

  4. Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium

    Veerle Compernolle

  5. Belgian Red Cross, Mechelen, Belgium

    Philippe Vandekerckhove

Authors
  1. Bert Avau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Van Remoortel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emmy De Buck
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Veerle Compernolle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philippe Vandekerckhove
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bert Avau.

Ethics declarations

Funding

Funding for this project has been provided partly through an Agreement with the European Blood Alliance (EBA) and partly by the Foundation for Scientiic Research of the Belgian Red Cross. The contents of this document do not necessarily relect the views and policies of the EBA, nor does mentioning of trade names or commercial products constitute endorsement or recommendation of use.

Conflict of interest

The authors are employees of Belgian Red Cross-Flanders, which is responsible for supplying adequate quantities of safe blood products to hospitals in Flanders and Brussels on a continuous basis and is funded by the Ministry of Social Affairs. Belgian Red Cross-Flanders received a grant from the European Blood Alliance to conduct the review this correspondence relates to.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

Not applicable.

Code availability

Not applicable.

Author's contributions

All authors read, contributed to and approved of the content of the manuscript.

Additional information

This author's reply refers to the letter to the editor at https://doi.org/10.1007/s40273-021-01083-w.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avau, B., Van Remoortel, H., De Buck, E. et al. Authors’ Response to “Preoperative Intravenous Iron for Iron Deficiency is Cost-Effective Prior to Major Elective Surgery”. PharmacoEconomics 40, 137–138 (2022). https://doi.org/10.1007/s40273-021-01084-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40273-021-01084-9

Search

Navigation